Imagenebio Inc (IMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,234 | -68,166 | -68,765 | -34,115 | -44,256 |
| Depreciation Amortization | -978 | -1,003 | 801 | 544 | 300 |
| Accounts payable and accrued liabilities | -1,169 | -2,870 | -291 | 361 | 519 |
| Other Working Capital | -3,979 | -21,669 | -15,138 | -33,032 | -7,771 |
| Other Operating Activity | 9,356 | 13,965 | 9,284 | 5,990 | 13,382 |
| Operating Cash Flow | $-46,004 | $-79,743 | $-74,109 | $-60,252 | $-37,826 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 435 | -414 | -1,431 | -1,760 | -766 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 3,688 |
| Purchase Of Investment | -88,298 | -90,052 | -216,338 | 0 | N/A |
| Sale Of Investment | 60,460 | 154,610 | 118,485 | 0 | N/A |
| Other Investing Activity | -7,500 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-34,903 | $64,144 | $-99,284 | $-1,760 | $2,922 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 37,557 | 1,095 | 131,884 | 13 |
| Common Stock Repurchased | N/A | -663 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 39,086 | 0 | -146 | 116,171 |
| Financing Cash Flow | $N/A | $75,980 | $1,095 | $131,738 | $116,184 |
| Beginning Cash Position | 121,172 | 60,791 | 233,089 | 163,363 | 82,083 |
| End Cash Position | 40,265 | 121,172 | 60,791 | 233,089 | 163,363 |
| Net Cash Flow | $-80,907 | $60,381 | $-172,298 | $69,726 | $81,280 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,004 | -79,743 | -74,109 | -60,252 | -37,826 |
| Capital Expenditure | N/A | -414 | -1,431 | -1,760 | -766 |
| Free Cash Flow | -46,004 | -80,157 | -75,540 | -62,012 | -38,592 |